RGT
Click for more information
0.00% 30.0¢ argent biopharma limited

is this dieter's unofficial apology on behalf of mgc? a...

  1. canplan
    416 Posts.
    lightbulb Created with Sketch. 135
    clock Created with Sketch.
    31/10/18
    17:53
    Post #: 36338207
    is this dieter's unofficial apology on behalf of mgc? a wishlist, if u will. put up the link.
    MXC Price at posting: 5.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

    3. This thread is closed.

    You may not reply to this discussion at this time.

 

Featured News

NEWS Quarterly exploration update reveals promising high-grade gold intercepts at Mt Gibson Gold Project, with potential for underground mining expansion
right-arrow Created with Sketch.
NEWS 'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers
right-arrow Created with Sketch.
NEWS $17 million placement to fund US launch of Remplir™ and drive further growth
right-arrow Created with Sketch.
NEWS Investee company secures biomedical AI accelerator grant to enhance anaesthetic management through data and AI advancements
right-arrow Created with Sketch.
NEWS $180,000 diamond drilling grant awarded for critical metals project to test promising mineralisation at depth
right-arrow Created with Sketch.
NEWS Javelin secures Eureka Gold Mine acquisition near Kalgoorlie, adding 112,000oz Au resource with plans for aggressive exploration in 2025
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $16.08M
Open High Low Value Volume
30.0¢ 30.0¢ 30.0¢ $77 257

Buyers (Bids)

No. Vol. Price($)
3 21556 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 105 1
View Market Depth
Last trade - 10.50am 28/10/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.